Celltrion to Invest 1.2 Trillion Won in South Korea to Expand Production Facilities
Incheon: Celltrion Inc., a major biopharmaceutical company, announced plans to invest 1.2 trillion won (US$805.6 million) in South Korea to expand its production facilities. This